The European Commission approves fully liquid presentation of GSK's meningococcal vaccine, Menveo, to protect against ...
With the pharmaceutical industry aiming to grow from $58 billion to $130 billion by 2030, he highlighted significant ...
PRNewswire New Delhi [India] November 28 The Organisation of Pharmaceutical Producers of India OPPI organized its flagship ...
GlobalData on MSN7h
EC approves GSK’s Menveo vaccine presentation for IMDThe European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine ...
Patients in low and middle-income countries (LMICs) are largely excluded from clinical trials by pharmaceutical companies, ...
Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...
Intellia Therapeutics received the FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for nexiguran ziclumeran ...
GSK's liquid meningitis vaccine, Menveo, received approval from the European Commission to be sold in the European Union. The British pharmaceutical company said Wednesday that the fully liquid ...
GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Smith from ...
GlaxoSmithKline (GSK) has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its regulatory ...
In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.
MDCX READ THE FULL V.MDCX RESEARCH REPORT IPO in U.S. Provides Additional Funding & Common Stock that Trades on Nasdaq On ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback